Chronic and Neuropathic Pain in MS Patients Should Be Routinely Evaluated, Study Says The next time a doctor tells you that there’s no pain associated with ... Read more
A diet rich in vegetables, fruits and whole grains may decrease symptoms and lessen disease progression in patients with multiple sclerosis, a study suggests.
Researchers enrolled 6,989 ... Read more
MMJ BioScience, an affiliate of medical cannabis research company MMJ International Holdings, has hired a principal investigator to lead clinical trials exploring potential therapeutic applications of ... Read more
Pain, walking problems and fatigue are factors that most strongly lower self-perceived health in multiple sclerosis, researchers at the New York University Langone Medical Center have found.
This ... Read more
A clear association was seen between the substantial pain that multiple sclerosis (MS) patients experience and lifestyle choices that either augment or ease that pain, like ... Read more
GT Biopharma has acquired licensing and development rights for PainBrake — Accu-Break Pharmaceuticals’ non-opioid pain medication to treat dysesthesia and pain caused by nerve damage ... Read more
It took two years and many doctors to finally receive my MS diagnosis. Frequent painful sensations, such as burning, itching, stabbing, and tingling in my arm ... Read more
As I write, I’m pain-free. This is important, but not for the obvious reason. I’m pain-free and can walk — or at least stumble — about as ... Read more
After 10-odd ― indeed, increasingly odd ― years, I presumed I’d become something of a gnarled hand at MS. If you read about something on practically ... Read more
Just when I thought I had experienced every multiple sclerosis (MS) symptom possible, another one emerges: sciatic nerve pain. It can happen to anyone, but it is ... Read more
AXIM Biotechnologies has secured an additional $4 million in institutional financing to advance clinical trials of its cannabinoid therapies for multiple sclerosis (MS) and irritable bowel syndrome. Some of the ... Read more
Axim Biotechnologies recently announced that its U.K. partner, Quay Pharmaceuticals, has secured licenses from the British Home Office to continue developing and importing its medical cannabinoid product MedChew Rx ... Read more
A significant percentage of multiple sclerosis (MS) patients struggle with improper diagnoses and ineffective treatments, a national survey of more than 5,300 patients found. The fifth ... Read more
For most of the 36 years since I was diagnosed with multiple sclerosis I’ve not been bothered by pain. Just lucky, I guess. Until last month. ... Read more
Half of the more than 7,500 multiple sclerosis (MS) patients responding to a recent survey revealed they’d consider physician-assisted suicide if they could no longer enjoy anything that ... Read more
Treatment with a compound called BIIB074 shows promise in reducing pain caused by trigeminal neuralgia — a condition that occasionally affects multiple sclerosis (MS) patients — with ... Read more
Regular massage therapy given people with multiple sclerosis (MS) significantly reduced their pain and fatigue, and helped to ease spasticity, a small pilot study reports. The results further support previous findings as ... Read more
Ninety-five percent of multiple sclerosis (MS) patients believe medical marijuana should be a treatment option, according to a GeneFo online survey. The survey also showed that almost 73 percent had ... Read more
Healthcare providers frequently assess multiple sclerosis (MS) patients for the development of other health conditions, such as depression, anxiety, pain and sleep disturbance, according to results ... Read more
AXIM Biotechnologies announced that the United States Patent and Trademark Office (USPTO) will be issuing a patent covering all cannabinoids — both natural and synthetic — used in a chewing ... Read more
Medical Marijuana announced that Axim Biotechnologies, a cannabinoid-based product developer in which it owns a strategic interest, has released a product pipeline chart highlighting development timelines for its cannabinoid-based therapeutics, ... Read more
AXIM Biotech has closed on a private funding round that will enable it to continue clinical trials for a variety of conditions, including its pharmaceutical candidate MedChew Rx, ... Read more
AXIM Biotechnologies announced it has secured financing from private sources to continue its testing of medical cannabinoid products as potential treatments for multiple indications, including pain and spasticity in ... Read more
I work full time in public health, and some days are spent ‘out in the field’ visiting clients in their homes. It requires careful planning to ... Read more
A researcher at De Montfort University Leicester (DMU)’s School of Nursing and Midwifery found that the practice of mindfulness helps people with long-term medical conditions, such as ... Read more
Montel Williams, a Naval Academy graduate diagnosed with multiple sclerosis (MS) in 1999 , recently announced the launch of a line of high-quality medical cannabis products ... Read more
Earth Life Sciences (ELS), a venture capital and management firm based in Quebec, announced that it is partnering with a cannabis oil-based nutraceutical company, with an agreement in ... Read more
Learn more about the invisible symptoms of multiple sclerosis. In this MS Society video, learn more about pain – an invisible symptom of multiple sclerosis. “Pain affects ... Read more
Transcutaneous electrical nerve stimulation (TENS) might be an option to treat spasticity, one of the more common symptoms of multiple sclerosis (MS), according to a literature ... Read more
In this MS Society video, learn more about pain – an invisible symptom of multiple sclerosis. “Pain affects about one-third of people with multiple sclerosis. Pain is ... Read more
Geoff Flynn, 42, was diagnosed with multiple sclerosis (MS) two and a half years ago. As unsettling as that diagnosis was, more troubling — both then and ... Read more
Read the Articles Here: MS Progression Halted Using Stem Cells Derived from Gum Tissue Can Cannabinoid Chewing Gum Treat Multiple Sclerosis Pain and Spasticity? Neuronal Repair ... Read more
MedChew Rx, by AXIM Biotechnology, Inc., the world’s first patented cannabinoid release chewing gum for pain and spasticity in multiple sclerosis (MS), is moving into clinical testing. ... Read more
In this video from the National Multiple Sclerosis Society: “Learn how pain and sleep disorders can often cause confusion and frustration for people with MS, their ... Read more
Cannabis is a plant that can be used in a wide range of settings such as medical purposes, a source of fiber and oils, or as a recreational ... Read more
Pin It on Pinterest
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. We never use your cookies for creepy ad retargeting that follows you around the web. OkRead more
